Group One Trading
VNDA icon

Group One Trading’s Vanda Pharmaceuticals VNDA Stock Holding History

Group One Trading’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Buy
292,400
+253,000
+642% +$1.95M ﹤0.01% 2061
2025
Q4 		$348K Buy
39,400
+35,400
+885% +$195K ﹤0.01% 3873
2025
Q3 		$20K Sell
4,000
-15,600
-80% -$72.2K ﹤0.01% 6697
2025
Q2 		$92.5K Sell
19,600
-10,000
-34% -$43.7K ﹤0.01% 5036
2025
Q1 		$136K Buy
29,600
+19,000
+179% +$88.6K ﹤0.01% 4353
2024
Q4 		$50.8K Sell
10,600
-134,800
-93% -$647K ﹤0.01% 5043
2024
Q3 		$682K Buy
145,400
+75,200
+107% +$403K ﹤0.01% 2625
2024
Q2 		$397K Buy
70,200
+40,100
+133% +$207K ﹤0.01% 2778
2024
Q1 		$124K Buy
30,100
+21,300
+242% +$85.3K ﹤0.01% 3967
2023
Q4 		$37.1K Buy
8,800
+5,500
+167% +$22.2K ﹤0.01% 5296
2023
Q3 		$14.3K Buy
3,300
+2,500
+313% +$13.9K ﹤0.01% 6132
2023
Q2 		$5.27K Buy
800
+300
+60% +$1.92K ﹤0.01% 6689
2023
Q1 		$3.4K Hold
500
– – ﹤0.01% 6450
2022
Q4 		$3.69K Sell
500
-10,200
-95% -$99.3K ﹤0.01% 6461
2022
Q3 		$106K Buy
10,700
+2,200
+26% +$23.2K ﹤0.01% 4727
2022
Q2 		$93K Buy
8,500
+8,200
+2,733% +$85K ﹤0.01% 5051
2022
Q1 		$3K Sell
300
-75,100
-100% -$987K ﹤0.01% 7660
2021
Q4 		$1.18M Buy
75,400
+75,300
+75,300% +$1.31M ﹤0.01% 3183
2021
Q3 		$2K Sell
100
-3,300
-97% -$57.8K ﹤0.01% 7974
2021
Q2 		$73K Sell
3,400
-3,600
-51% -$64.4K ﹤0.01% 6250
2021
Q1 		$105K Buy
7,000
+2,700
+63% +$43.7K ﹤0.01% 5620
2020
Q4 		$57K Sell
4,300
-2,300
-35% -$27.7K ﹤0.01% 4935
2020
Q3 		$64K Buy
+6,600
New +$70.5K ﹤0.01% 4485
2020
Q2 		– Sell
-4,000
Closed -$41K – 6221
2020
Q1 		$41K Buy
+4,000
New +$49.6K ﹤0.01% 3844
2019
Q4 		– Sell
-100
Closed -$1K – 5664
2019
Q3 		$1K Sell
100
-400
-80% -$5.58K ﹤0.01% 5020
2019
Q2 		$7K Sell
500
-11,400
-96% -$181K ﹤0.01% 4528
2019
Q1 		$219K Sell
11,900
-22,500
-65% -$513K ﹤0.01% 2627
2018
Q4 		$899K Buy
34,400
+29,700
+632% +$698K 0.01% 1584
2018
Q3 		$108K Buy
4,700
+2,500
+114% +$51K ﹤0.01% 3482
2018
Q2 		$42K Sell
2,200
-4,600
-68% -$76.9K ﹤0.01% 4048
2018
Q1 		$115K Buy
6,800
+3,300
+94% +$55.2K ﹤0.01% 3168
2017
Q4 		$53K Sell
3,500
-89,900
-96% -$1.33M ﹤0.01% 3701
2017
Q3 		$1.67M Buy
93,400
+72,600
+349% +$1.21M 0.02% 1180
2017
Q2 		$339K Sell
20,800
-2,500
-11% -$36K ﹤0.01% 2250
2017
Q1 		$326K Buy
23,300
+14,700
+171% +$209K ﹤0.01% 2172
2016
Q4 		$137K Sell
8,600
-4,500
-34% -$72.3K ﹤0.01% 2659
2016
Q3 		$218K Buy
13,100
+10,700
+446% +$144K ﹤0.01% 2414
2016
Q2 		$27K Sell
2,400
-1,200
-33% -$11.6K ﹤0.01% 3656
2016
Q1 		$30K Sell
3,600
-5,700
-61% -$46.8K ﹤0.01% 3535
2015
Q4 		$87K Sell
9,300
-40,800
-81% -$407K ﹤0.01% 3074
2015
Q3 		$565K Buy
50,100
+19,300
+63% +$236K 0.01% 1678
2015
Q2 		$391K Sell
30,800
-37,200
-55% -$401K 0.01% 1993
2015
Q1 		$632K Sell
68,000
-88,300
-56% -$998K 0.01% 1433
2014
Q4 		$2.24M Buy
156,300
+37,800
+32% +$447K 0.03% 594
2014
Q3 		$1.23M Sell
118,500
-233,400
-66% -$3.06M 0.02% 958
2014
Q2 		$5.69M Buy
351,900
+75,500
+27% +$1.01M 0.09% 249
2014
Q1 		$4.49M Sell
276,400
-15,600
-5% -$222K 0.08% 265
2013
Q4 		$3.62M Buy
292,000
+63,900
+28% +$642K 0.05% 366
2013
Q3 		$2.5M Buy
228,100
+99,500
+77% +$1.06M 0.05% 450
2013
Q2 		$1.04M Buy
+128,600
New +$866K 0.03% 795

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's VNDA Position: Q1 2026 in Review

Group One Trading sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 54,341 shares — an estimated $419K sold.

Group One Trading first reported a position in VNDA in Q2 2013 and held it in 36 quarters. The position peaked at $2.75M in Q4 2013. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Group One Trading reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 54,341 Vanda Pharmaceuticals shares in Q1 2026, an estimated $419K.
  • Group One Trading first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 36 quarters.
  • Group One Trading's Vanda Pharmaceuticals position peaked at $2.75M in Q4 2013.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.